Boothbay Fund Management »

Sensei Biotherapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $823k 26k 31.52

More positions owned by Boothbay Fund Management

At&t Call Option (T)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Tesla Motors Call Option (TSLA)
Abivax Sa Sponsored Ads (ABVX)
Ge Aerospace Com New Call Option (GE)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Microsoft Corporation Put Option (MSFT)
Amazon Call Option (AMZN)
Cornerstone Strategic Value (CLM)
Mineralys Therapeutics Put Option (MLYS)
United Therapeutics Corporation Call Option (UTHR)
Constellation Brands Cl A Call Option (STZ)

View all positions for Boothbay Fund Management

Top funds holding Sensei Biotherapeutics

Vivo Capital
Cormorant Asset Management
Millennium Management
Franklin Resources
Stempoint Capital
Trails Edge Capital Partners
Goldman Sachs Group
Hrt Financial
Suvretta Capital Management
Bank of America Corporation
Logos Global Management
Boothbay Fund Management
Brevan Howard Capital Management
Fred Alger Management
Balyasny Asset Management

View all funds holding Sensei Biotherapeutics